Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Neural Regeneration Research · 2024-09 · 19 (9) · 1890-1898
DOI: 10.4103/1673-5374.390964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neural Regeneration Research, online erschienen am 15.12.2023. Verfasst von Qiuqin Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Scientific Research, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, China. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Previous studies have demonstrated a bidirectional relationship between inflammation and depression. Activation of the nucleotide-binding oligomerization domain, leucine-rich repeat, and NLR family pyrin domain-containing 3 (NLRP3) inflammasomes is closely related to the pathogenesis of various neurological diseases. In patients with major depressive disorder, NLRP3 inflammasome levels are significantly elevated. Understanding the role that NLRP3 inflammasome-mediated neuroinflammation plays in the pathogenesis of depression may be beneficial for future therapeutic strategies. In this review, we aimed to elucidate the mechanisms that lead to the activation of the NLRP3 inflammasome in depression as well as to provide insight into therapeutic strategies that target the NLRP3 inflammasome. Moreover, we outlined various therapeutic strategies that target the NLRP3 inflammasome, including NLRP3 inflammatory pathway inhibitors, natural compounds, and other therapeutic compounds that have been shown to be effective in treating depression. Additionally, we summarized the application of NLRP3 inflammasome inhibitors in clinical trials related to depression. Currently, there is a scarcity of clinical trials dedicated to investigating the applications of NLRP3 inflammasome inhibitors in depression treatment. The modulation of NLRP3 inflammasomes in microglia holds promise for the management of depression. Further investigations are necessary to ascertain the efficacy and safety of these therapeutic approaches as potential novel antidepressant treatments.
Autor:innen und Institutionen
- Department of Scientific Research, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
- Department of Traditional Chinese Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Physiology, Laboratory of Neurodegenerative Diseases, Changzhi Medical College, Changzhi, Shanxi Province, China.
ORCID-Profile: Qiuqin Han, Guobin Liu, Xiaorong Chen
Zitieren
APA
Han, Q., Li, W., Chen, P., Wang, L., Bao, X., Huang, R., Liu, G., & Chen, X. (2024). Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression. Neural Regeneration Research, 19(9), 1890-1898. https://doi.org/10.4103/1673-5374.390964
Vancouver
Han Q, Li W, Chen P, Wang L, Bao X, Huang R, et al. Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression. Neural Regeneration Research. 2024;19(9):1890-1898. doi:10.4103/1673-5374.390964
BibTeX
@article{Han2024,
author = {Han, Qiuqin and Li, Wenhui and Chen, Peiqing and Wang, Lijuan and Bao, Xiwen and Huang, Renyan and Liu, Guobin and Chen, Xiaorong},
title = {Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression},
journal = {Neural Regeneration Research},
year = {2024},
volume = {19},
number = {9},
pages = {1890--1898},
doi = {10.4103/1673-5374.390964}
}
EUVIMED